Urethral bulking agents for the treatment of female stress urinary incontinence

[1]  P. Latthe,et al.  Management of complications arising from the use of mesh for stress urinary incontinence—International Urogynecology Association Research and Development Committee opinion , 2019, International Urogynecology Journal.

[2]  E. Illiano,et al.  Transobturator mid-urethral sling in females with stress urinary incontinence and detrusor underactivity: effect on voiding phase , 2019, International Urogynecology Journal.

[3]  I. Giarenis,et al.  Changing surgical trends for female stress urinary incontinence in England , 2018, International Urogynecology Journal.

[4]  K. Gradel,et al.  A Danish national population-based cohort study of synthetic midurethral slings, 2007–2011 , 2018, International Urogynecology Journal.

[5]  S. Jha,et al.  National BSUG audit of stress urinary incontinence surgery in England , 2018, International Urogynecology Journal.

[6]  T. Serdinšek,et al.  Long-term results of two different trans-obturator techniques for surgical treatment of women with stress and mixed urinary incontinence: a 10-year randomised controlled study follow-up , 2018, International Urogynecology Journal.

[7]  G. Sotgiu,et al.  Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis , 2018, International Urogynecology Journal.

[8]  J. Roovers,et al.  Patients’ perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence , 2018, International Urogynecology Journal.

[9]  S. McClinton,et al.  Urethral injection therapy for urinary incontinence in women. , 2017, The Cochrane database of systematic reviews.

[10]  Z. Siddiqui,et al.  Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review , 2017, International Urogynecology Journal.